Skip to main content
. 2021 May 26;49(5):03000605211017000. doi: 10.1177/03000605211017000

Table 3.

Comparison of the incidence of side effects and newborn Apgar scores.

Side effects Group R (n = 56) Group RS (n = 56) χ2/T P
Pruritus 0 0 <0.0001 1.00
Nausea, vomiting 16 4 4.3768 0.03
Newborn Apgar score 1 minute 9.05 ± 0.43 9.14 ± 0.34 0.1342 0.55
5 minutes 10.00 10.00 <0.0001 1.00

Data are mean ± standard deviation or number. In group R, women received 0.75% isobaric ropivacaine intrathecally; in group RS, women received 0.75% isobaric ropivacaine plus 5 μg sufentanil intrathecally.